Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders.

@article{Paiva2010UtilityOF,
  title={Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders.},
  author={Bruno Paiva and Julia Almeida and Mart{\'i}n P{\'e}rez-Andr{\'e}s and Gema Mateo and Antonio Dopico L{\'o}pez and Ana Rasillo and Mar{\'i}a Bel{\'e}n Vidriales and Mar{\'i}a-Consuelo L{\'o}pez-Berges and Jes{\'u}s San Miguel and Alberto Orfao},
  journal={Cytometry. Part B, Clinical cytometry},
  year={2010},
  volume={78 4},
  pages={239-52}
}
In recent years, multiparameter flow cytometry (MFC) immunophenotyping has become mandatory in the clinical management of hematological malignancies, both for diagnostic and monitoring purposes. Multiple myeloma (MM) and other clonal plasma cell-related (PC) disorders should be no exception to this paradigm, but incorporation of immunophenotypic studies in the management of patients with PC disorders is still far from being routinely established in many diagnostic flow cytometry laboratories… CONTINUE READING